Earlier today, the Democratic Party of Oregon came out in support of Measure 91, which would legalize and regulate the adult use, cultivation, and sale of marijuana in the state.
These endorsements were made by a “voting body comprised of the State Central Committee delegates, alternates, and associates.” A measure required a two-thirds vote for or against for the Party to take an official position.
In a press release highlighting their supportive position, the Democratic Party of Oregon stated that “a majority of Americans and large majority of Democrats now support state regulation of legal marijuana use. Measure 91 is the right approach to legalization in Oregon, strictly regulating use while funding law enforcement and schools. Vote Yes on 91.”
You can read the full release here.
You can learn more about Measure 91, including ways you can donate or volunteer, by visiting their website here.
NORML will be providing much more coverage on this and other ballot initiatives as election season heats up. Stay tuned.
As I prepared to leave for the Seattle Hempfest, a lovely celebration of all things related to marijuana, I could not help but think about what a wonderful time it is right now for those of us who smoke marijuana. We have the best quality marijuana in the world grown right here in the US, and even in those regions of the country that do not yet offer legal marijuana, the selection of different strains on the black market is outstanding. Of course, in those states with some version of legal marijuana, that selection is also conveniently available in retail outlets (at least for those who qualify).
When I began smoking marijuana in the mid-1960s, the question we generally asked the dealer-man was simple: do you have anything available? It was a simple yes-or-no question; and seldom did he have more than one or two strains. And worst of all, during the late summer and early fall, while we were waiting for the marijuana harvest to finish and work its way through the inefficient black market network from field to consumer, most years we experienced what we called a “drought.” During these droughts, there was simply no marijuana available, or at least nothing other than ditchweed, which was not worth smoking. Those dry periods would usually last for several weeks. But eventually we would get the word that the supply system was once again working, and we could again stock-up with a supply of adequate, but seldom great weed.
As best I can recall, I generally paid about $60 per ounce, so the cost was affordable, and there was usually an even less expensive version for those who were looking for a bargain, although I think most of that lower quality marijuana was likely headed for the college campuses all across America. According to a recent article published by the IvyGate website, citing a review of pot prices at all Ivy League schools published by the Yale Daily News in 1971, prices at the Ivy League colleges at the time were as low $8 and as high as $25 (for the best quality, usually obtained from Vietnam vets) per ounce. And the quality of what we then thought of as good marijuana would not compare favorably with what we routinely get today, whether from the black market or from a legal market.
The administration of a single dose of whole-plant cannabis via a thermal-metered inhaler is effective and well tolerated among patients suffering from neuropathy (nerve pain), according to clinical trial data published online ahead of print in the Journal of Pain and Palliative Care Pharmacotherapy.
Israeli investigators assessed the efficacy of a novel, portable metered-dose cannabis inhaler in eight subjects diagnosed with chronic neuropathic pain. Researchers reported that the device administered an efficient, consistent, and therapeutically effective dosage of cannabinoids to all participants.
They concluded, “This trial suggests the potential use of the Syqe Inhaler device as a smokeless delivery system of medicinal cannabis, producing a delta-9-THC pharmacokinetic profile with low inter-individual variation of (maximum drug/plasma concentrations), achieving pharmaceutical standards for inhaled drugs.”
A series of clinical trials conducted by investigators affiliated with the Center for Medicinal Cannabis Research at the University of California, San Diego previously determined that the inhalation of whole-plant cannabis is efficacious in the treatment of neuropathic pain.
Full text of the study, “The pharmacokinetics, efficacy, safety, and ease of use of a novel portable metered-dose cannabis inhaler in patients with chronic neuropathic pain: A phase 1a study,” will appear in the Journal of Pain and Palliative Care Pharmacotherapy.
Nearly seven out of ten Pennsylvania voters believe that marijuana should be legal for either medicinal or recreational use, according to the results of a statewide survey released by Keystone Analytics.
Sixty-nine percent of respondents said that cannabis should be made legal under state law, with 47 percent of voters endorsing its medicinal use and another 22 percent agreeing with the statement, “It should be legal for any adult to use for any reason.”
Twenty-seven percent of respondents believed that cannabis “is a harmful substance that should remain illegal to buy and use in Pennsylvania.”
The poll possesses a margin of error of +/- 4.4 percent.
House and Senate legislation (HB 1181/SB 1182) seeking to authorize cannabis therapy to qualified patients remains pending in the state. A Senate floor vote on the measure is expected when lawmakers return from their summer recess.
In coming months, the Pennsylvania State Nurses Association will be holding a series of educational seminars on the subject of cannabis and its potential therapeutic application. The Association is on record in support of “the establishment of efficient drug (cannabis) delivery, growing and dispensing systems as contained within SB 1182.”
Sixty-six percent of Americans believe that adults ought to legally be able to consume cannabis in the privacy of one’s own home, according to results of a nationwide HuffingtonPost/YouGov survey released late last week.
Seventy-two percent of self-identified Democrats and 70 percent of Independents said that the private consumption of cannabis should be legal. Republican respondents endorsed private consumption by a margin of 50 percent to 39 percent.
Fifty-five percent of respondents — including 62 percent of Democrats and 60 percent of Independents — also said that they supported statewide laws seeking to tax and regulate the commercial production and retail sale of cannabis to adults, such as those recently enacted in Colorado and Washington. By contrast, only 37 percent of Republicans said they supported such a plan.
The HuffPost/YouGov survey possesses a margin of error of +/- 3.9 percent.